Ihab Roushdy Kamel, M.D., Ph.D.

Headshot of Ihab Roushdy Kamel
  • Vice-Chair of MR Operations and MR Innovation
  • Professor of Radiology and Radiological Science

Languages: English, Arabic


Diagnostic Radiology, Magnetic Resonance Imaging (MRI), Radiology ...read more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Johns Hopkins Bayview Medical Center

Appointment Phone: 443-997-7237
4940 Eastern Avenue
Baltimore, MD 21224 map
Phone: 443-997-1811

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 443-997-7237
1800 Orleans St.
Baltimore, MD 21287 map
Phone: 410-955-4100 | Fax: 410-955-9799

Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center)

Appointment Phone: 443-997-7237
601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-955-4100

Johns Hopkins Medicine - White Marsh

Appointment Phone: 443-997-7237
4924 Campbell Boulevard
Suite 105
White Marsh, MD 21236 map
Phone: 443-442-2401 | Fax: 443-451-6986

Johns Hopkins Medical Imaging - Columbia

Appointment Phone: 443-997-7237
11055 Little Patuxent Parkway
Columbia Medical Center, Suite L9
Columbia, MD 21044 map
Phone: 443-574-5800 | Fax: 443-451-6986

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 443-997-7237
10803 Falls Road
Pavilion III, Suite 1100
Lutherville, MD 21093 map
Phone: 410-583-2700 | Fax: 443-451-6986


Dr. Ihab Kamel is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science and the Department of Oncology. Dr. Kamel served as the Clinical Director of MRI at Johns Hopkins University until December 2019.  He served as Chairman of the Department of Imaging and Imaging Sciences at Johns Hopkins Bayview Medical Center until July 2021. He currently serves as Vice-Chair of MR Operations and MR Innovation and is a member of the Johns Hopkins Kimmel Cancer Center. His work focuses on body imaging, with expertise in hepatobiliary and pancreatic imaging.

He earned his M.D. from Cairo University in Cairo, Egypt and his M.S. and Ph.D. from University of Michigan in Ann Arbor, MI. He completed his residency at New York Medical College and performed a fellowship in body imaging at Beth Israel Deaconess Medical Center in Boston, MA. He joined the Johns Hopkins faculty in 2000 as an Assistant Professor. In 2005, he became Associate Professor and in 2013 became Professor of Radiology and Oncology.

Dr. Kamel received the Fleischner Young Investigator Award from the Harvard Medical School in 2000. In 2004 he received the Faculty Teacher of the Year award for the Department of Radiology at Johns Hopkins Hospital and was recognized in 2008 as a Melvin M. Figley Fellow in Radiology Journalism from the American Roentgen Ray Society (ARRS). In 2015 Dr. Kamel was awarded the Honored Educator Award from the Radiological Society of North America (RSNA).

Dr. Kamel is an expert in utilizing functional MRI to quantify early tumor response to therapy. He is also an authority in hepatobiliary and pancreatic imaging. He has coauthored over 280 articles in peer-reviewed journals and 25 book chapters. Dr. Kamel is Chair of the GI section of the American College of Radiology Appropriateness Criteria, and he sits on numerous national and international radiological society committees. 


...read more


  • Vice-Chair of MR Operations and MR Innovation
  • Professor of Radiology and Radiological Science
  • Professor of Oncology

Departments / Divisions

Centers & Institutes



  • MD; Cairo University Medical College (1983)


  • Radiology; Metropolitan Hospital Center - New York Medical College (1997)
  • Radiology; New York Medical College (1998)
  • Diagnostic Radiology; Theodor Bilharz Research Institute (1989)


  • Radiology; Mount Sinai Beth Israel Medical Center (2000)

Board Certifications

  • American Board of Radiology (Diagnostic Radiology) (1998)

Research & Publications

Clinical Trials

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy

Development and validation of quantitative MRI biomarkers of iron overload: A multi institutional study



Selected Publications

View all on PubMed

1.         Kamel IR, Hernandez RJ, Martin JE, Schlesinger AE, Niklason LT, Guire KE.  Radiation dose reduction in CT of the pediatric pelvis.  Radiology.  1994 Mar;190(3):683-687.  PMID: 8115611

2.         Kamel IR, Berkowitz JF.  Assessment of the cortical rim sign in post-traumatic renal infarction.  J Comput Assist Tomogr.  1996 Sep-Oct; 20(5):803-6.  PMID: 8797917

3.         Kamel IR, Goldberg SN, Keogan MT, Rosen MP, Raptopoulos V.  Right lower quadrant pain and suspected appendicitis: non-focused appendiceal CT - review of 100 cases.  Radiology.  2000 Oct; 217(1):159-63.  PMID: 11012439

4.         Kamel IR, Raptopoulos V, Pomfret EA, Kruskal JB, Kane RA, Yam CS, Jenkins RL.  Living adult right lobe liver transplantation:  imaging before surgery with multidetector multiphase CT.  AJR.  2000 Oct; 175(4):1141-3.  PMID: 11000179

5.         Kamel IR, Kruskal JB, Pomfret EA, Keogan MT, Warmbrand G, Raptopoulos V.  Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation.   AJR.  2001; 176(1):193-200. PMID: 11133565

6.         Keogan MT, Lo JY, Freed KS, Raptopoulos V, Blake S, Kamel IR, Weisinger K, Rosen MP, Nelson RC.  Outcome analysis of patients with acute pancreatitis by using an artificial neural network.  Acad Radiol.  2002 Apr; 9(4):410-9. PMID: 11942655

7.         Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, Ahmed M, Raptopoulos V.  Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy.  AJR.  2002 Jul; 179(1):93-101. PMID: 12076912

8.         Tekes A, Kamel IR, Imam K, Chan TY, Schoenberg MP, Bluemke DA.  MR imaging features of transitional cell carcinoma of the urinary bladder.  AJR.  2003 Mar; 180(3):771-7. PMID: 12591695

9.         Tekes A, Kamel IR, Chan TY, Schoenberg MP, Bluemke DA.  MR imaging features of non-transitional cell carcinoma of the urinary bladder with pathologic correlation.  AJR.  2003 Mar; 180(3):779-84. PMID: 1259169

10.      Kamel IR, Choti MA, Horton KM, Braga HJ, Birnbaum BA, Fishman EK, Thompson RE, Bluemke DA.  Surgically staged focal liver lesions: Accuracy and reproducibility of dual-phase helical for detection and characterization.  Radiology.  2003 Jun;227(3):752-7. PMID: 12773679

11.      Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF.  Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma.   AJR.  2003 Sep;181(3):708-10. PMID: 12933464

12.      Kamel IR, Lawler LP, Fishman EK.  Variations in anatomy of the middle hepatic vein and their impact on formal right hepatectomy.  Abdom Imaging.  2003 Sep-Oct; 28(5):668-74. PMID: 14628873

13.      Monsky WL, Raptopoulos V, Keogan MT, Doty D, Kamel IR, Yam CS, Ransil BJ.  Reproducibility of linear tumor measurements using PACS: comparison of caliper method with edge-tracing method.  Eur Radiol.  2004 Mar; 14(3):519-25. PMID: 14658000

14.      Li AE, Kamel IR, Rando F, Anderson M, Kumbasar B, Lima JA, Bluemke DA.  Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age.  AJR.  2004 Mar; 182(3):593-7. PMID: 14975953

15.      Kamel IR, Hochman MG, Keogan MT, Eng J, Longmaid HE 3rd, DeWolf W, Edelman RR.  Accuracy of breath-hold MR imaging in preoperative staging of organ-confined renal cell carcinoma. J Comput Assist Tomogr.  2004 May-Jun; 28(3):327-32. PMID: 15100535

16.      Kamel IR, Cohade C, Neyman E,  Fishman EK, Wahl RL.  Incremental value of CT in PET/CT of patients with colorectal carcinoma.  Abdom Imaging. 2004 Nov-Dec; 29(6):663-8. PMID: 15162236

17.      Liapi E, Kamel IR, Bluemke DA, Jacobs MA, Kim HS.  Assessment of response of uterine fibroids and myometrium to embolization using diffusion-weighted echoplanar MR imaging.  J Comput Assist Tomogr.  2005 Jan-Feb; 29(1):83-6. PMID: 15665689

18.      Fayad LM, Kamel IR, Mitchell DG, Bluemke DA.  Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree.  AJR. 2005 May; 184(5):1563-71. Review.  PMID: 15855116

19.      Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.  The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.  J Vasc Interv Radiol. 2006 Mar; 17(3):505-12. PMID: 16567675

20.      Moff SL, Kamel IR, Eustace J, Lawler LP, Kantsevoy S, Kalloo AN, Thuluvath PJ.  Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc. 2006 Aug; 64(2):219-23. PMID: 16860072

21.      Kamel IR, Reyes DK, Liapi E, Bluemke DA, and Geschwind JH.  Functional MR imaging assessment of tumor response following 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.  J Vasc Interv Radiol. 2007 Jan; 18(1 Pt 1):49-56.  PMID: 17296704

22.      Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.  Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug; 18(8):957-63. PMID: 17675611

23.      Liapi E, Geschwind JH, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR.  Functional MR imaging evaluation of tumor response in patients with neuroendocrine hepatic metastases treated with transcatheter arterial chemoembolization.  AJR. 2008 Jan; 190(1):67-73. PMID: 18094295

24.      Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR.   Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI.  AJR. 2008 Jul; 191(1):285-9. PMID: 18562760

25.      Chang KJ, Kamel IR, Macura KJ, Bluemke DA. 3.0-T MR imaging of the abdomen: comparison with 1.5 T.  Radiographics. 2008 Nov-Dec; 28(7):1983-98. Review.  PMID: 19001653

26.      Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety. Radiographics. 2009 Jan-Feb; 29(1):9-22.  PMID: 19019996

27.      Bonekamp S, Kamel IR, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol. 2009 Jan; 50(1):17-35. Review.  PMID: 19022517

28.      Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF.  Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after TACE as detected by MR imaging. Radiology.  2009 Feb;250(2):466-73. PMID: 19188315

29.      Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto Ventura V, Lee KH, Bluemke DA, Kamel IR.  Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced MR imaging for the characterization of tumor necrosis in an animal model.  J Comput Assist Tomogr. 2009 Jul-Aug; 33(4):626-630.  PMID: 19638862

30.      El Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.  Radiology. 2010 Jul; 256(1):64-73. PMID: 20574085

31.      Bonekamp S, Shen J, Salibi N, Lai HC, Geschwind JF, Kamel IR.  Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted MR imaging and proton magnetic resonance spectroscopy.  J Comput Assist Tomogr. 2011 Mar-Apr; 35(2):167-73. PMID: 21412085

32.      Hernaez R, Lazo M, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis.  Hepatology. 2011 Sep 2;54(3):1082-90. PMID: 21618575

33.      Bonekamp D, Reyes DK, Bonekamp S, Wahlin TA, Geschwind JF, Fishman EK, Kamel IR.  Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI.  Emerg Radiol. 2011 Jun; 18(3):249-56. PMID: 21327446

34.      Buijs M, Vossen JA, Geschwind JF, Salibi N, Pan L, Ventura VP, Liapi E, Lee KH, Kamel IR.  Quantitative proton MR spectroscopy as biomarker of tumor necrosis in the rabbit VX2 liver tumor.  J Vasc Interv Radiol. 2011 Aug; 22(8):1175-80. PMID: 21620723

35.      Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR.  Hepatocellular carcinoma response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.  Radiology. 2011 Sep; 260(3):752-61.  PMID: 21771960

36.      Malayeri AA, El Khouli RH, Zaheer A, Jacobs MA, Villalobos CP, Kamel IR, Macura KJ.  Principles and applications of diffusion-weighted imaging in cancer detection, staging and treatment follow-up.  Radiographics.  2011 Oct; 31(6):1773-91.  PMID: 21997994

37.      Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick K, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR.  A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.  Ann Intern Med. 2011 Oct 4; 155(7):415-24.  PMID: 21969340

38.      Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF.  Phase II trial of sorafenib combined with concurrent TACE with drug eluting beads for hepatocellular carcinoma.  J Clin Oncol.  2011 Oct 20; 29(30):3960-7.  PMID: 21911714

39.      Bonekamp S, Torbenson MS, Kamel IR.  Diffusion-weighted MR imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011 Nov; 45(10):885-92. PMID: 21716125

40.      Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 2011 Nov 18;343.  PMID: 22102439

41.      Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell  J, Goggins M; American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012 Apr;142(4):796-804.  PMID: 22245846

42.      Halappa VG, Bonekamp S, Corona-Villalobos CP, Li Z, Mensa M, Reyes D, Eng J, Bhagat N, Pawlik TM, Geschwind JF, Kamel IR. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology. 2012 Jul;264(1):285-94. PMID: 22627601

43.      Li Z, Bonekamp S, Halappa VG, Corona-Villalobos CP, Pawlik T, Bhagat N, Reyes  D, Lai H, Geschwind JF, Kamel IR. Islet Cell Liver Metastases: Assessment of Volumetric Early Response with Functional MR Imaging after Transarterial Chemoembolization. Radiology. 2012 Jul;264(1):97-109. PMID: 22627602

44.      Halappa VG, Villalobos CP, Bonekamp S, Gearhart SL, Efron J, Herman J, Kamel IR. Rectal imaging: part 1, high-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol. 2012 Jul;199(1):W35-42. PMID: 22733930

45.      Georgiades C, Geschwind JF, Harrison N, Hines-Peralta A, Liapi E, Hong K, Wu Z, Kamel I, Frangakis C. Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? Radiology. 2012 Oct;265(1):115-23. PubMed PMID: 22891361.

46.      Gowdra Halappa V, Corona Villalobos CP, Bonekamp S, Gearhart SL, Efron J, Herman J, Kamel IR. Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol. 2012 Jul;199(1):W35-42. Review. PubMed PMID: 22733930.

47.      Hernaez R, McLean J, Lazo M, Brancati FL, Hirschhorn JN, Borecki IB, Harris TB, Nguyen T, Kamel IR, Bonekamp S, Eberhardt MS, Clark JM, Kao WH, Speliotes EK; Genetics of obesity-related liver disease (GOLD) Consortium. Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B with Ultrasound-Defined Steatosis Based on Data from the NHANES III. Clin Gastroenterol Hepatol. 2013 Sep;11(9):1183-1190.e2. PubMedPMID: 23416328.

48.      Corona-Villalobos CP, Pan L, Halappa VG, Bonekamp S, Lorenz CH, Eng J, Kamel IR. Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 Tesla in phantom and in soft tissues of the abdomen. J Comput Assist Tomogr. 2013 Jan;37(1):46-51. PubMed PMID: 23321832.

49.      Gage KL, Deshmukh S, Macura KJ, Kamel IR, Zaheer A. MRI of perianal fistulas: bridging the radiological-surgical divide. Abdom Imaging2013 Oct;38(5):1033-42. PubMed PMID: 23242265.

50.      Gowdra Halappa V, Corona-Villalobos CP, Bonekamp S, Li Z, Reyes D, Cosgrove D, Pawlik TM, Diaz LA, Bhagat N, Eng J, Geschwind JF, Kamel IR. Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology. 2013 Feb;266(2):502-13. PubMed PMID: 23192780.

51.      Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013 Mar;62(3):339-47. PubMed PMID: 23135763.

52.      Pokharel SS, Macura KJ, Kamel IR, Zaheer A. Current MR Imaging Lipid Detection Techniques for Diagnosis of Lesions in the Abdomen and Pelvis. Radiographics. 2013 May;33(3):681-702. PubMed PMID: 23674769.

53.      Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, Bhagat N, Cosgrove DP, Pawlik TM, Mezey E, Eng J, Kamel IR. UnresectableHepatocellular Carcinoma: MR Imaging after Intraarterial Therapy. Part II. Response Stratification Using Volumetric Functional Criteria after Intraarterial  Therapy. Radiology2013 Aug;268(2):431-9. PubMed PMID: 23616632.

54.      Bonekamp S, Li Z, Geschwind JF, Halappa VG, Corona-Villalobos CP, Reyes D, Pawlik TM, Bonekamp D, Eng J, Kamel IR. Unresectable Hepatocellular Carcinoma: MR Imaging after Intraarterial Therapy. Part I. Identification and Validation of Volumetric Functional Response Criteria. Radiology2013 Aug;268(2):420-30.  PubMed PMID: 23616631.

55.      Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM.Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013 Jul 1;178(1):38-45. PMID:23703888

56.      te Riele AS, Bhonsale A, James CA, Rastegar N, Murray B, Burt JR, Tichnell C, Madhavan S, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H.  Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.  J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9. PMID:23810894

57.      Te Riele AS, James CA, Philips B, Rastegar N, Bhonsale A, Groeneweg JA, Murray B, Tichnell C, Judge DP, Van Der Heijden JF, Cramer MJ, Velthuis BK, Bluemke DA, Zimmerman SL, Kamel IR, Hauer RN, Calkins H, Tandri H.  Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced.  J Cardiovasc Electrophysiol. 2013 Dec;24(12):1311-20. PMID:23889974

58.      Hyder O, Dodson RM, Weiss M, Cosgrove DP, Herman JM, Geschwind JF, Kamel IR, Pawlik TM. Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma. J Gastrointest Surg. 2013 Oct;17(10):1774-83. PMID:23943387

59.      Ou HY, Bonekamp S, Bonekamp D, Corona-Villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. AJR Am J Roentgenol. 2013 Oct;201(4):W596-602.  PMID:24059398

60.      Bonekamp S, Bonekamp D, Geschwind JF, Corona-Villalobos CP, Reyes DK, Pawlik TM, Kamel IR. Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. J Magn Reson Imaging. 2013 Nov 8.  PMID:24214827

61.      Torkzad MR, Kamel I, Halappa VG, Beets-Tan RG. Magnetic resonance imaging of rectal and anal cancer. Magn Reson Imaging Clin N Am. 2014 Feb;22(1):85-112. PMID:24238134

62.      Bonekamp D, Bonekamp S, Halappa VG, Geschwind JF, Eng J, Corona-Villalobos CP, Pawlik TM, Kamel IR. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma. Eur J Radiol. 2014 Mar;83(3):487-96. PMID:24387824

63.      Yarmish GM, Smith MP, Rosen MP, Baker ME, Blake MA, Cash BD, Hindman NM, Kamel IR, Kaur H, Nelson RC, Piorkowski RJ, Qayyum A, Tulchinsky M. ACR Appropriateness Criteria Right Upper Quadrant Pain. J Am Coll Radiol. 2014 Mar;11(3):316-22. PMID:24485592

64.      Burt JR, Zimmerman SL, Kamel IR, Halushka M, Bluemke DA. Myocardial t1 mapping: techniques and potential applications. Radiographics. 2014 Mar-Apr;34(2):377-95. PMID:24617686

65.      El Khouli RH, Macura KJ, Kamel IR, Bluemke DA, Jacobs MA. The Effects of Applying Breast Compression in Dynamic Contrast Material-enhanced MR Imaging. Radiology. 2014 Jul;272(1):79-90. PubMed PMID: 24620911.

66.      Corona-Villalobos CP, Kamel IR. Functional Volumetric MRI in Assessing Treatment Response to Intra-Arterial Therapy of Primary and Secondary Liver Tumors. J Comput Assist Tomogr. 2014 Jul-Aug;38(4):513-7. Review. PubMed PMID: 24681851.

67.      Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Hutfless S, Salamone A, Kiswani V, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Wolfgang CL. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol.  2014 Oct;21(11):3668-74. PubMed  PMID: 24806116.

68.      Bonekamp D, Bonekamp S, Ou HY, Torbenson MS, Corona-Villalobos CP, Mezey E, Kamel IR. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging. J Magn Reson Imaging. 2014 Nov;40(5):1137-46. PubMed PMID: 24989329.

69.      Chapiro J, Wood LD, Lin M, Duran R, Cornish T, Lesage D, Charu V, Schernthaner R, Wang Z, Tacher V, Savic LJ, Kamel IR, Geschwind JF. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology. 2014 Dec;273(3):746-58. PubMed PMID: 25028783.

70.      te Riele AS, James CA, Rastegar N, Bhonsale A, Murray B, Tichnell C, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H. Yield of serial evaluation in at-risk family members of patients with ARVD/C. J Am Coll Cardiol.  2014 Jul 22;64(3):293-301. PubMed PMID: 25034067.

71.      Corona-Villalobos CP, Halappa VG, Geschwind JF, Bonekamp S, Reyes D, Cosgrove D, Pawlik TM, Kamel IR. Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. Eur Radiol. 2015 Feb;25(2):380-90. PubMed PMID: 25226843.

72.      Rastegar N, Burt JR, Corona-Villalobos CP, Te Riele AS, James CA, Murray B, Calkins H, Tandri H, Bluemke DA, Zimmerman SL, Kamel IR. Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy. Radiographics. 2014 Oct;34(6):1553-70. Review. PubMed PMID: 25310417.

73.      Zhang Y, Corona-Villalobos CP, Kiani AN, Eng J, Kamel IR, Zimmerman SL, Petri M. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus. Int J Cardiovasc Imaging. 2015 Feb;31(2):389-97. PubMed PMID: 25352245.

74.      Baker ME, Nelson RC, Rosen MP, Blake MA, Cash BD, Hindman NM, Kamel IR, Kaur H, Piorkowski RJ, Qayyum A, Yarmish GM. ACR Appropriateness Criteria® acute pancreatitis. Ultrasound Q. 2014 Dec;30(4):267-73. PubMed PMID: 25364960.

75.      Corona-Villalobos CP, Halappa VG, Bonekamp S, Eng J, Reyes D, Cosgrove D, Rastegar N, Pan L, Pawlik TM, Kamel IR. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma. Invest Radiol. 2015 Apr;50(4):283-9. PubMed PMID: 25396692.

76.      Rastegar N, Zimmerman SL, Te Riele AS, James C, Burt JR, Bhonsale A, Murray B, Tichnell C, Judge D, Calkins H, Tandri H, Bluemke DA, Kamel IR. Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations. JACC Cardiovasc Imaging. 2014 Nov 12. pii: S1936. PubMed PMID: 25457767.

77.      Myers KS, Kamel IR, Macura KJ. MRI-guided breast biopsy: outcomes and effect on patient management. Clin Breast Cancer. 2015 Apr;15(2):143-52. PubMed PMID: 25499596.

78.      Rastegar N, Matteoni-Athayde LG, Eng J, Takahashi N, Tamm EP, Mortele KJ, Syngal S, Margolis D, Lennon AM, Wolfgang CL, Fishman EK, Hruban RH, Goggins M, Canto MI, Kamel IR. Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol. 2015 Apr;84(4):575-80. PubMed PMID: 25619503.

79.      Groeneweg JA, Bhonsale A, James CA, Te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Jan Cramer M, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Jun;8(3):437-46. PubMed PMID: 25820315.

80.      Cosgrove DP, Reyes DK, Pawlik TM, Feng AL, Kamel IR, Geschwind JF. Open-Label  Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results. Radiology. 2015 Jun 11:142481. [Epub ahead of print] PubMed PMID: 26069923.


Activities & Honors


  • Gold Medal Award, 2000 SGR Annual meeting, 2000
  • Bronze Medal Award, 2000 ARRS Annual meeting, 2000
  • Fleischner Young Investigator Award, Beth Israel Deaconess Medical Center and Harvard Medical School, 2000
  • RSNA Fellowship Research Trainee Prize, 2000 RSNA Annual meeting, 2000
  • Silver Medal Award, 31st Annual International Radiology meeting, 2001
  • Cum Laude Award, 2001 RSNA Annual meeting, 2001
  • Cum Laude Award, Society of computed body tomography and magnetic resonance (SCBT/MR), 2004
  • Faculty Teacher of the Year, Johns Hopkins Hospital, 2004
  • Melvin M. Figley Fellow in Radiology Journalism, ARRS, 2008
  • Honored Educator Award, 2015 RSNA Annual Meeting, 2015

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button